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ABSTRACT The I-J subregion of the mouse major histocom-
patibility complex has been reported to encode antigenic deter-
minants expressed by suppressor T cells. Previously, cosmid clones
were obtained from mouse sperm DNA that contain all of the se-
quences between the I-A and I-E subregions, where I-J has been
mapped genetically. However, hybridization of these sequences
to RNA prepared from several I-J-positive suppressor T-cell hy-
bridomas did not reveal the presence of a transcript. In addition,
no rearrangements in this DNA were detected in the suppressor
T cells that we have analyzed. Our results indicate that the I-J
polypeptides are not encoded between the I-A and I-E subregions
of the major histocompatibility complex. We discuss several hy-
potheses concerning the possible location and expression of I-J
genes.
The I region of the murine major histocompatibility complex
(MHC) encodes polymorphic cell surface molecules that are in-
volved in lymphocyte interactions (1, 2). The I region has been
divided by analysis of recombinant inbred mice into five subre-
gions arranged in the order I-A, I-B, I-J, I-E, I-C (3). The I-A
and I-E subregions code for class II molecules or Ia antigens,
which are found predominantly on the surfaces of B cells and
macrophages (4, 5). These molecules are composed of two poly-
peptides, an a chain of approximately 32,000 daltons and a (
chain of approximately 28,000 daltons (6). To elicit an immune
response, some T lymphocytes, mostly helper T cells, must rec-
ognize syngeneic class II molecules in addition to the stimu-
lating antigen (7, 8). The other subregions, I-B, I-J, and I-C,
are less well characterized. For example, while the I-B subre-
gion may affect the level of the immune response to certain
antigens, it does not encode serologically detectable molecules
and its existence is controversial (9, 10). On the other hand,
numerous alloantisera and monoclonal antibodies have been
raised against lymphocytes from strains that differ only in the
I-j subregion (11-14). The antigens recognized by these anti-
bodies have a unique distribution; they are found predomi-
nantly on the surface of suppressor T cells and on soluble fac-
tors with suppressive activity secreted by these cells (11-16).
In addition, I-J-positive subsets of helper T lymphocytes (17)
and macrophages (18) have been detected. Interest in the I-J
subregion and its gene products has been heightened by two
findings. First, I-J-encoded molecules are associated with or
are actually part of the antigen-binding polypeptides made by
suppressor T cells (19-21). Thus, a biochemical characterization
of I-J molecules may help to define the T-cell antigen receptor.
Second, in some cases I-J-encoded molecules appear to regu-
late interactions between T lymphocytes (22).
There are several reports indicating that the I-J determinant
is present on proteins with a molecular mass of approximately
25,000 daltons (20, 21, 23). In addition, because the I-J serolog-
ical determinant can be found on proteins translated in vitro by
a rabbit reticulocyte lysate, the antigenic determinant is pre-
sumed to be a polypeptide rather than a carbohydrate structure
(23). Little more is known, however, about the structure of I-
J-encoded molecules.
Recently, a 2.0-kilobase (kb) DNA sequence has been de-
fined that should contain the gene(s) encoding the I-J serologi-
cal determinant (24, 25). Using two human cDNA probes spe-
cific for DR. and DCq, we have isolated 200 kb of contiguous
I region sequence from BALB/c mouse (H-2d) DNA. The cod-
ing sequences for the Ep3 chain from the I-A subregion and the
Ea chain from the I-E subregion were found to be separated by
only 33 kb of DNA (24). Next, to define more precisely the
boundaries of the I-A and I-E subregions, we identified poly-
morphic restriction enzyme sites in the I region and tested ge-
nomic DNA from parental and I-region recombinant strains for
the presence of these polymorphic sites (24, 25). This analysis
permitted us to correlate the genetic map of the I region with
the molecular map of the cosmid cluster. We discovered that
the boundaries of the I-A and I-E subregions, which define I-
J, are less than 2.0 kb apart (see Fig. 1).11 The distance sepa-
rating these subregions might be smaller than 2.0 kb, but no
polymorphic restriction enzyme sites have been found to per-
mit characterization of this segment of DNA.
There are two reasons why this region seems too small to
encode the I-J polypeptides. First, the 2.0-kb sequence is ac-
tually contained within the E,3 gene and includes part of the
intron between the first ((31) and second ((32) major exons and
probably all of the second major exon ((32) of the Ep gene (see
Abbreviations: kb, kilobase(s); MHC, major histocompatibility complex.
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1lThe 2.0-kb sequence is defined on the left side (I-A) by a polymorphic
restriction site that distinguishes H-2b from H-2d DNA and on the right
side (I-E) by a site that distinguishes H-2k from H-2S (25). The locali-
zation of I-j to the 2.0-kb sequence therefore assumes that both anti-
I-Jb and anti-I-Jk plus anti-I-Js alloantisera recognize a specificity en-
coded either by the same or else a nearby exon of the I-J gene. If this
is not the case, then the I-J gene may be encoded in a somewhat longer
sequence. However, it should be noted that the 8.48 and 8.47 RNA
blot hybridization probes covered approximately 12 kb of DNA in this
region (Fig. 1).
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Fig. 1). Second, distinct I-f-encoded specificities have been
detected on different T-cell subpopulations or cloned T cells,
suggesting that the I-f subregion could in fact contain several
genes (26-28). To resolve this problem, we have proposed sev-
eral models for the location and expression of the I-J gene(s)
(24). The models are summarized below.
1. The I-f gene is encoded between the I-A and I-E subre-
gions. (a) The I-J gene is actually the Ep gene. The I-J speci-
ficity is formed via special post-translational modification (e.g.,
glycosylation) of the E,3 gene product. (b) The I-J gene is formed
via an alternative RNA splicing pattern that includes some of
the Ep exons and some exons unique to I-J. (c) The I-J gene is
transcribed from the DNA strand complementary to that which
encodes the Ep gene. (d) The I-1 gene is formed by a DNA rear-
rangement in suppressor T lymphocytes, which inserts some
coding sequences between the I-A and I-E subregions.
2. The I-J structural gene is not encoded between the I-A
and I-E subregions. (a) Because of the occurrence of multiple
recombination events, the map order I-A/I-f/I-E is incorrect.
(b) The I-f subregion contains a control element that regulates
the expression of I-f genes encoded elsewhere. (c) The I-J sero-
logic determinants are not encoded in the MHC. These de-
terminants may be present on T-cell receptors for self MHC
molecules.
In this paper, we report experiments that exclude models 1
a-d, which propose that the I-f gene is located between the I-
A and I-E subregions. The remaining models (2 a-c), which pro-
pose that the I-J coding sequence is located elsewhere, are con-
sidered in the Discussion.
MATERIALS AND METHODS
RNA and Southern Blots. Blot hybridization experiments
were carried out as described (29, 30). To reduce background
caused by the hybridization of repeat nucleotide sequences in
the probes, both the prehybridization and hybridization solu-
tions contained denatured BALB/c liver DNA at 25 ,ug/ml.
The filters were washed with 15 mM NaCl/1.5 mM sodium
citrate/0. 1% NaDodSO4 at 68%C and exposed to Kodak XAR-
5 film in the presence of an intensifying screen for 4 days.
Hybridization Probes. Hybridization probes derived from
the I region included the sequences diagrammed in Fig. 1. 8.48
and 8.47 are 7.2- and 4.8-kb HindIl restriction fragments from
cosmid 8.4, which were subcloned into pBR325 by standard
methods (31, 32). Probe 3, a 2-kb EcoRI restriction fragment
derived from cosmid 24.2, and probe 4, a 500-base-pair Sau3A
fragment purified from cosmid 39.1, have been described (24).
pH-21Ia is a 688-base-pair Pst I/Pvu II subclone from a cDNA
clone encoding an H-2d transplantation antigen (33).
RESULTS
Transcripts Homologous to the Presumed 1-J Subregion Are
Not Detectable in Suppressor T Cells. To identify I-J tran-
scripts, we analyzed 13 suppressor T-cell hybridomas for the
presence of RNA molecules that hybridize to cloned DNA probes
containing the putative I-f subregion. Some properties of these
suppressor cells (nos. 1-13) are summarized in Table 1. All of
the hybridomas were tested with anti-I-J alloantisera, anti-I-J
monoclonal antibodies, or both (refs. 14, 27, 34-36; unpub-
lished data). In each of 13 cases tested, the cells produced an
I-J-positive suppressor factor. Furthermore, eight out of eight
hybridomas tested were positive for cell-surface I-J determi-
nants. Because extensive sequence polymorphism might greatly
reduce hybridization of probes derived from the H-2d haplo-
type to transcripts derived from other strains, we tested one
hybridoma generated from a fusion with BALB/c lympho-
Table 1. Characteristics of suppressor T-cell hybridomas
T-parental I-Ji
H-2 Antigen Suppressor Cell
No. Hybridoma haplotype* specificityt factor surface
1 258C4.4 q GAT/GA + +
2 342B1.11 s GAT/GT + +
3 365C6.4 s GAT NT +
4 367A5.2 k GT + +
5 368B1.5 d GT/GAT + NT
6 301D4.5 f GT + NT
7 301A2.3 f GT + NT
8 469B5.5 a GT/GAT + NT
9 372B3.5 b GAT/GT + +
10 372D6.5 b GAT/GT + +
11 395A4.4 s GT/GAT + NT
12 7C3-13 k NP + +
13 7F4-30 k NP + +
14 366D3.2 b GT/GAT + NT
NT, not tested.
*All the hybridomas were formed by fusion of lymphocytes to the
hypoxanthine/aminopterin/thymidine-sensitive AKR thymoma
BW5147, andthey therefore containH-2k haplotypeDNA contributed
by the tumor parent.
tAntigen-binding specificities of T-hybridoma suppressor factors. GA
is a synthetic poly(Glu6OAla"4); GAT is poly(Glu6MAla30Tyr'0); GT is
poly(Glu~Tyr50); NP is 4-hydroxy-3-nitrophenyl acetyl. In all cases,
the immunogen is listed first followed by any other known specific-
ities.
I-J specificities found on the suppressor T-cell hybridomas or on their
secreted factors.
cytes, the same inbred strain from which the cosmid clone bank
had been prepared. Blots of poly(A)+ RNA from each of the T
cells were hybridized with a mixture of 32P-labeled subclones
8.48 and 8.47 (Fig. 1), which together contain the Ep gene and
all of the DNA between the I-A and I-E subregions. As shown
in a set of characteristic blots that were hybridized in parallel
(Fig. 2), there was no evidence of a transcript homologous to
the probe in any of the suppressor T-cell RNA that we ana-
lyzed. Each of the RNA preparations was tested independently
on at least two blots (Fig. 2; unpublished data). Since MHC-
encoded transplantation antigens are expressed by most cell
types, rehybridization of the same RNA blots with pH-211a, a
probe encoding an H-2d transplantation antigen, provided a
positive control for the presence of intact RNA. Although the
hybridomas transcribe various amounts of RNA homologous to
this probe, a distinct 1.9-kb band was detected in each case
(unpublished data). To determine the detection limit of the RNA
blots, additional control hybridizations were carried out using
subclones 8.48 and 8.47 and various amounts of spleen poly(A)+
RNA. We could detect hybridization of the Ep coding sequencein these subclones to 0.1-0.3 jig of spleen RNA. To estimate
the abundance of the Ep transcript in spleen poly(A)+ RNA, we
compared the Ep hybridization signal to the signal obtained with
a K light chain constant-region probe hybridized to various
amounts of purified S107 myeloma K chain RNA. This per-
mitted us to correlate the intensity of hybridization bands on
autoradiograms with the number of picograms of complemen-
tary RNA present. In this manner, we estimated that the Ep
RNA represents approximately 0.03% of the spleen poly(A)+
RNA (unpublished data). Similar estimates for the abundance
of class II mRNA have been reported from other laboratories
(37-39). Fig. 2 shows that we could detect a RNA species that
is 0.03% of 0.3 ,ug spleen RNA tested. Thus, we should have
been able to detect sequences present at less than one part in
105 contained in the 10 ,ug of T-cell RNA analyzed. Since the
Immunology: Kronenberg et al.
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FIG. 1. Genetic and molecular map of the Iregion. The same 19-kb sequence is depicted inA, B, and C. (A) Boundaries oftheI-A andI-E subre-
gions as previously determined (24, 25). I-B has been omitted because it is confined to the same 2.0-kb sequence asI-J and codes for no serologically
detectable product. (B) Positions and lengths of the hybridization probes. (C) Locations of some Ep exons as determined by Southern blot hybrid-ization (25) and the direction of transcription of the Ep gene. (31 and 2 code for the first and second external domains, respectively, while TM indi-
cates the transmembrane/cytoplasmic exon(s).
Ep RNA is about 1,300 nucleotides long and T-cell hybridomas
generally contain 0.2-0.3 pg of poly(A)+ RNA per cell (40), our
detection limit is roughly 3 or 4 copies per cell.
The I-J Gene Is Not Formed by Rearrangement of DNA
Sequences Between the I-A and I-E Subregions. We wished to
determine whether a DNA rearrangement in suppressor T cells
might be necessary to form a complete I-J gene. High molec-
ular weight DNA that was prepared from four T-cell hybri-
domas (342B1. 11, 366D3.2, 372B3.5, and 395A4.4) was di-
A
0.3/ig 38Lg
B
9 7 5 1 2 6
gested with one of several restriction enzymes, and the digests
were hybridized with probe 3, probe 4, or a mixture of sub-
clones 8.47 and 8.48 (Fig. 1). When the hybridization pattern
obtained from the T-cell hybridomas was compared with that
of liver DNA of the appropriate MHC haplotype, no DNA
rearrangements were observed on any of these Southern blots.
From the I-region restriction map of the liver DNA (24), we
concluded that in each case the restriction fragment(s) detected
should include the entire sequence between the I-A and I-E
subregions. Fig. 3 shows some cases in which the enzyme di-
gest allowed us to distinguish between those restriction frag-
ments derived from the normal T-cell parent and those from
the BW5147 fusion partner.
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FIG. 2. Hybridization of subclones 8.48 and 8.47 to spleen poly(A)+
RNA (A) and to 10 gg of suppressor T-cell poly(A)+ RNA (B). T-cell hy-
bridomas are designated as numbered in Table 1. RNA preparations on
several different filters were hybridized with the subclones. Migration
distances of the molecular weight markers, mouse and Escherichia coli
ribosomal RNA, and their lengths in kb are indicated.
DISCUSSION
Using a series of cosmids, it was previously determined that the
boundaries of the I-A and I-E subregions are separated by only
2.0 kb of DNA (24, 25). This analysis confines the serologically
assigned l-J subregion to a relatively short sequence that is ac-
tually located within the En gene (Fig. 1). A number of ex-
perimental results have convinced us that the BALB/c cosmid
DNA map is an accurate representation of the germ line se-
quences found between the En and Ea genes. First, we have
obtained seven different overlapping cosmid clones containing
all or part of the DNA between Ep and E, (24). This eliminates
the possibility that the map fuses noncontiguous sequences and
thereby misses a gene. Second, extensive comparison of the
restriction enzyme maps between BALB/c mice and other strains
indicate that the BALB/c genomic DNA contains neither a
deletion nor an inversion breakpoint between the E,3 and E,"
genes (24, 25). Finally, we have obtained cosmid DNA clones
from the AKR inbred strain, which has a MHC haplotype (H-
2k) different from BALB/c. In this strain, the En and E,,, genes
are also separated by approximately 33 kb (unpublished data).
We have found no evidence for an I-J coding sequence lo-
cated between the I-A and I-E subregions. If some I-J exons
were present between the I-A and I-E subregions, there could
be two reasons for failing to detect them. (i) When cloned sup-
pressor hybridomas are grown in vitro, the I-J serologic spec-
Proc. Natl. Acad. Sci. USA 80 (1983)
TS
E.
FIG. 3. Southern blots of T-suppressor hybridoma DNA. Lanes 1-
6:KpnI-igestedDNAhybridized to probe 3-1, BW5147thymoma (H-
2k); 2BO liver (H-2b); 3, 372B3.5 suppressor (H-2b/H-2k);4, AKR liver
(H-2 ); 5, B1O.S liver (H-2T); 6, 395A4.4 suppressor (H-2T/H-2k). Lanes
7-9: BamHI-digestedDNA hybridized to probe 3-7, AKR liver (H-2k);
8, 372B3.5 (H_2bl/H2k); 9,B10 liver (H-2b). Migration distances ofsome
molecular weight markers are indicated in kb.
ificities can often be detected on only a fraction of the cells (26,
27). Thus, if many cells in a population do not express an I-J
polypeptide, the average concentration of I-J transcripts could
be extremely low. Although the cells used for RNA purification
were tested for antigen-specific function, we cannot state what
fraction displayed I-J serologic determinants at the time of har-
vest. However, it seems improbable that such a low level of I-
J transcription, with little quantitative variation, would be
maintained in each of 13 suppressor T cells grown in two dif-
ferent laboratories and shown' to express high levels of antigen-
specific suppressor activity. (ii) It is possible that only a single
exon, encoding a small portion of the i-f gene product, actually
is located between the I-A and I-E subregions. A polymorphic
sequence, which perhaps could be as small as the immuno-
globulin D gene segment, would not have been detected on a
RNA blot. Such a short segment could be co-expressed with
other exons located outside the 2.0-kb sequence by RNA splic-
ing. However, we have hybridized cosmid probes spanning most
of the 200 kb of cloned I-region DNA to blots of poly(A)+ RNA
from two suppressor T cells and have not detected any com-
plementary sequences (unpublished data). Therefore, any short
exon between the I-A and I-E subregions would have to be
present on an extremely large primary transcript originating
outside the sequences we have cloned. The minimum length
of such a transcript, assuming that the I-J exon is located at one
of the ends of the mRNA, would be appropriately 60 kb. Al-
ternatively, a short exon encoding the polymorphic I-J deter-
minant could be co-expressed with other exons after a DNA
rearrangement. However, gene rearrangement was not ob-
served on Southern blots of four suppressor T cells. Because
the DNA from these cells was tested after digestion with sev-
eral different restriction enzymes (Fig. 3 and unpublished data),
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it is unlikely that the DNA was fortuitously rearranged to the
same size restriction fragment as is present in the germ line.
In addition, any relevant rearrangement should have been de-
tected because the hybridizing, restriction fragments include all
the DNA between the I-A and I-E subregions. Finally, al-
though a small insertion (-250 base pairs) would not greatly
augment the size of the hybridizing restriction fragments and
therefore might not have been detected, a larger insertion would
be required to form an I-J structural gene. We therefore con-
clude that the I-J gene is not formed by a DNA rearrangement
between the I-A and I-E-subregions.
Our data suggest that the genes encoding I-J serologic de-
terminants expressed by suppressor T cells do not map between
the I-A and I-E subregions. There are several possibilities to
explain the discrepancy between the immunogenetic and mo-
lecular maps. (i) It may be that I-J is linked to the MHC but the
assigned map position is incorrect. The genetic mapping is based
on analysis of a few recombinant mice and the reasonable as-
sumption that multiple crossovers are rare. Yet in some regions
of the mouse genome, multiple crossovers are relatively com-
mon (41). If multiple crossovers in the I region were the rule
rather than the exception, then conceivably I-J could have an
apparent map position between I-A and I-E even though it is
located elsewhere in the MHC. However, it should be noted
that we do not know of any documented cases of double re-
combinants involving the well-characterized MHC loci. (ii) Each
inbred mouse strain may contain several pseudoallelic I-J genes
and a regulatory locus that determines the I-J gene expressed.
To explain the reported properties of I-J gene products, the
regulatory locus must be polymorphic, it must map between
the I-A and I-E subregions, and it must regulate expression of
the pseudoallelic genes in a haplotype-specific manner. There
are no proven examples of such a polymorphic regulatory se-
quence. (iii) I-J may map outside of the MHC, perhaps even
to another chromosome. Although it is difficult to reconcile the
genetic map with this hypothesis, the recombinant congenic
mice used to define I-J also may differ at a non-MHC locus that
is involved in suppression. There are several mechanisms that
could then lead to an apparent map position for the I-J serologic
determinant between the I-A and I-E subregions. For example,
the I-J serologic determinants may not be present on I-region
encoded molecules but instead may be located on molecules
encoded elsewhere that recognize En. This is possible because
some T cells have antigen receptors that recognize either self
class II molecules or a complex of antigen with self class II poly-
peptides. If receptors that recognize the same Ep allele tend
to have common serologic determinants, regardless of the non-
MHC genetic background of the strain involved, then the ap-
parent genetic map position of these receptors will be the Em
gene itself. However, it should be noted that receptors for class
II molecules are best characterized for helper as opposed to
suppressor T cells. In addition, some inbred mouse strains do
not express an I-E molecule and therefore may not express Em
(42), while some strains that express different I-J alleles may
have identical En genes (43).
Our experiments indicate that I-J exons are not likely to be
present between the boundaries of the I-A and I-E subregions.
While none of the three alternative models for the location of
the I-J gene is entirely satisfactory, the possibility of a high fre-
quency of multiple crossovers leading to an incorrect map order
for the subregions of the I-region is -most attractive, because
this hypothesis requires the fewest ad hoc assumptions and spe-
cial mechanisms to account for the reported data. We have cloned
the recombination point between the I-A and.I-E subregions in
several I-region recombinant strains (25). Further character-
ization of these. recombinants as well as the isolation of cloned
Immunology: Kronenberg et al.
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sequences encoding the I-J polypeptide will finally resolve the
paradox of I-J gene location and expression.
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